This is a service of EIN News a digital news provider
Pharmaceutical Industry Today
Sign up for a free trial
Register Now
Member center Log In
California Generic Drugs News is an EIN News Service for pharmaceuticals professionals. Constantly updated news and information about California Pharmaceuticals.
FORMATS: RSS | EMAIL

Latest California Generic Drugs News

Sort by: relevance (24 hours) relevance date
  • Neurogen Corp. reports $1.9M loss, sells real estate 7 Nov 2009 11:57 GMT
    ... August it would be acquired by Ligand Pharmaceuticals Inc., a California company that will not ... decreased spending on Neurogen’s clinical and preclinical drug development programs as well as work force ... already are or will be available in generic forms by the time aplindore could be ...

  • Neurogen Corp. reports $1.9M loss, sells real estate [New Haven Register, Conn.] 7 Nov 2009 13:05 GMT
    ... August it would be acquired by Ligand Pharmaceuticals Inc., a California company that will not ... decreased spending on Neurogen's clinical and preclinical drug development programs as well as work force ... already are or will be available in generic forms by the time aplindore could be ...

  • Symyx Direct 6.3 Adds Markush Str... 6 Nov 2009 13:30 GMT
    ... SUNNYVALE, Calif. - Symyx Technologies, Inc. (NASDAQ:SMMX) has released ... library design and patent claim analysis in drug discovery by greatly expanding the techniques available for ... large number of compounds as a single, generic entry by identifying a core structure and ...

  • Bayer Goes to Court over Yaz 6 Nov 2009 16:48 GMT
    ... popular oral contraceptive was responsible for a California woman's stroke. Susan Galinis, just 39 years ... key issue with Yaz, Yazmin and the generic version of the pill, Ocella, appears to ... death. "There are no benefits to this drug, and there are greater risks," lawyer Michael Danko ...

  • Make it easy to create these generic drugs 5 Nov 2009 05:35 GMT
    ... trials. Bapineuzumab is one of the first drugs with the potential to treat the root ... most proven ways to lower drug prices: generic competition. There is currently no FDA approval ... ambiguous language that provides loopholes to allow pharmaceutical companies to renew this 12-year protection over ...

  • 11-03-09 EUR ALL ON ONE PAGE... 3 Nov 2009 09:29 GMT
    ... to help lower the cost of prescription drugs by voting for legislation that would give ... exclusive rights to sell a drug before generic – yet comparably effective- versions of the ... be a new more natural form of pharmaceutical. Anybody who has paid for a prescription ...

  • Valeant Pharmaceuticals Reports Third Quarter Financial Results 2 Nov 2009 13:55 GMT
    ... VIEJO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced third quarter ... quarter of 2008. Product sales in Branded Generics - Latin America were $40.7 million in ... collaboration partner GSK, completed both the New Drug Application (NDA) and the Marketing Authorisation Application ...

  • Expensive drugs could face generic competition, but not as quickly as some want 1 Nov 2009 22:32 GMT
    ... - Rob Day is grateful there's a drug he can take to alleviate the constant ... medicine. He can't switch to a cheaper, generic version of Soliris because there isn't one. Pharmaceuticals made from chemicals face competition from generics ...

  • Amid Obama barbs at Fox News, HMOs; PhRMA emerges as an unlikely Dem ally 3 Nov 2009 12:50 GMT
    ... recently launched attacks at several groups, but pharmaceutical companies have dodged the administration’s ire. The ... the administration’s ire. President Barack Obama bashed drug companies on the campaign trail, but the ... Democratic proposals to open the market to generic versions, called biosimilars or follow-on biologics, of ...

  • BUYINS.NET: EP, ATPG, SVNT, IFLO, HIBB, OREX Expected To Be Lower Leading Up To Next Earnings Releases 3 Nov 2009 09:37 GMT
    ... ATP Oil and Gas (NASDAQ: ATPG), Savient Pharmaceuticals (NASDAQ: SVNT), I-flow Corp (NASDAQ: IFLO), Hibbett ... The company sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary ...

  • Why Do Pharmas Call Themselves Biotechs? 3 Nov 2009 15:14 GMT
    ... There's a particularly annoying trend in the drug business whereby companies that aren't in the ... with Biologics as opposed to a typical Pharma commercial model, clinical trial topics relevant to ... (at the end of the patent, many generics enter the space and pretty much wipe ...

  • Corona-based Watson Pharmaceuticals announces $63 million profit [The Press-Enterprise, Riverside, Calif.] 5 Nov 2009 23:33 GMT
    ... Corona-based Watson Pharmaceuticals announces $63 million profit [The Press-Enterprise, Riverside, ... announces $63 million profit [The Press-Enterprise, Riverside, Calif.] Press-Enterprise (Riverside, CA) - Nov. 05, 2009 ... per share. Watson, which makes branded and generic medications, has launched several products in the ...

  • THE JOURNAL OF STEFFANIE RIVERS: Do The ... 3 Nov 2009 08:10 GMT
    ... to help lower the cost of prescription drugs by voting for legislation that would give ... exclusive rights to sell a drug before generic – yet comparably effective- versions of the ... be a new more natural form of pharmaceutical. Anybody who has paid for a prescription ...

  • THE JOURNAL OF STEFFANIE RIVERS: Do The Right Thing 3 Nov 2009 09:04 GMT
    ... to help lower the cost of prescription drugs by voting for legislation that would give ... exclusive rights to sell a drug before generic – yet comparably effective- versions of the ... be a new more natural form of pharmaceutical. Anybody who has paid for a prescription ...

  • Corona-based Watson Pharmaceuticals announces $63 million profit 5 Nov 2009 23:34 GMT
    ... Corona-based Watson Pharmaceuticals announces $63 million profit Nov 04, 2009 ... per share. Watson, which makes branded and generic medications, has launched several products in the ... . Copyright (c) 2009, The Press-Enterprise, Riverside, Calif. Distributed by McClatchy-Tribune Information Services. For reprints, ...


1 - 15 / 135      NEXT >>>

Powered by Newsfeed Maker
NOT SATISFIED WITH THIS CALIFORNIA GENERIC DRUGS NEWS SECTION? MAKE YOUR OWN WITH THE INBOX ROBOT OR TRY OUR OTHER MEDIA MONITORING SERVICES.
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>>
 
 

Take This Poll

According to the White House, 650,000 jobs were created or saved by $150 billion in stimulus funds. Was it money well spent? (Oct. 30, 2009)



 

BUSINESS PROMOTION SERVICES

EIN Advertising · Place banner ads on EIN News industry specific publications.

EIN Presswire · Upload press releases to the EIN network and have them submitted to leading journalists and decision-makers worldwide.

EIN Global Events · Reach industry-specific readers and promote events, conferences or exhibitions.

EIN Business Directory · Present company or service information on highly-visible, industry and geo-specific news pages.

NEWS SERVICES

News Publications · In-depth geopolitical and industry specific news coverage aggregated from 35,000 online outlets. Updated every 15 minutes.

News Alerts · Receive a free selection of the day's top stories hand picked by EIN News editors.

Newsfeed Maker · Integrate customized newsfeeds in any format covering all industry and geopolitical topics, updated every 15 minutes.

EIN Presswire · Upload press releases to the EIN network and have them submitted journalists and decision-makers worldwide.

Inbox Robot · Customized newsletters delivered by e-mail. Search a news index monitoring thousands of trusted media sources.

COMPANY BACKGROUND

About EIN News · Established in 1995, EIN News began by supplying business professionals and individuals with relevant and interesting news products. It has grown to become the largest digital news provider in Europe.

Member List · See the partial member list and join a community of professionals from private industry, institutions, and governments that rely on EIN as a critical source for research, breaking news and media services.